SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001354488-16-006140
Filing Date
2016-02-10
Accepted
2016-02-09 21:58:19
Documents
2
Period of Report
2016-02-04
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ecte8k_feb2016.htm 8-K 26997
2 PROMISSORY NOTE WITH BEIJING YI TANG BIO SCIENCE & TECHNOLOGY, LTD. DATED FEBRUA ex10-1.htm EX-10.1 16701
  Complete submission text file 0001354488-16-006140.txt   45218
Mailing Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830
Business Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830 732-549-0919
Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)

IRS No.: 411649949 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35218 | Film No.: 161401925
SIC: 3845 Electromedical & Electrotherapeutic Apparatus